News
This edition of Market Factors includes a thematic investing approach uncovering stocks that outperform. New stresses in the ...
An economist explains what the latest data shows—and doesn't show—about the affordable housing crisis in California ...
Additionally, it has enjoyed good customer retention throughout its cloud transition and is experiencing solid annual contract value growth. However, Pegasystems has displayed inconsistencies on the ...
Jeffrey Sherman, DoubleLine Capital deputy CIO, joins 'Money Movers' to discuss JPMorgan CEO Jamie Dimon's bond market ...
For a fleeting moment Monday morning, 20-year bonds were no longer offering the highest yields on the US Treasuries curve.
BlackRock emphasized that it has long warned of the minimal risk premium investors have accepted for holding Treasuries, and ...
U.S. Treasury yields moved lower on Tuesday as the OECD slashed the U.S. growth outlook on tariff uncertainty, and continued ...
12h
The Punch on MSNInflation erodes real pension returns – TrustFund bossThe Managing Director and Chief Executive Officer of TrustFund Pensions Limited, Mr Uche Ihechere, has said that inflationary ...
Spain 20 Year Government Bond 0.039 3.726% ...
Investing.com -- Genmab (NASDAQ: GMAB) has unveiled new data for its cancer drug Rina-S, which is being tested for use in endometrial cancer. This follows promising early results from trials in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results